FB2026_02 , released June 18, 2026
FB2026_02 , released June 18, 2026
Human Disease Model Report: depression-like behaviors (postulated), MIR184-related
Open Close
General Information
Name
depression-like behaviors (postulated), MIR184-related
FlyBase ID
FBhh0001050
Disease Ontology Term
Parent Disease
OMIM
Overview

The human miRNA MIR184 was identified from a RNA-seq experiment comparing miRNA expression from participants with late-life depression and controls. MIR184 has also been linked to a rare eye disease, EDICT syndrome (MIM:614303).

There is an orthologous miRNA in Drosophila, mir-184 (see FBrf0215696). Amorphic alleles, fluorescently tagged constructs, overexpression constructs, and a "sponge" sequestering construct have been generated for mir-184.

The human gene MIR184 has not been introduced into flies.

Flies lacking mir-184 have higher locomotor activity compared to controls at 11-15 days post eclosion, but lower locomotor activity at 21-25 days post eclosion. mir-184 knockout flies also have worse short- and long-term memory of an aversive odor stimulus than controls. Conversely, flies overexpressing mir-184 show better locomotor activity and memory than controls. The biological pathways and processes predicted to be affected by mir-184 were mainly related to the regulation of the immune-inflammatory processes (MAP kinase, Calmodulin-kinases, NF-kappa B signaling pathway), second messenger signaling (TRP channels activation, regulation of activation of G protein in gated potassium channels calcium signaling pathway, GABA receptor activation), metabolic control (insulin signaling pathway), neurotrophic support (neurotrophic signaling pathway, VEGF signaling pathway), proteostasis and senescence-related pathways (mTOR signaling pathway).

[updated June 2019 by FlyBase; FBrf0222196]

Disease Summary Information
Disease Summary: depression-like behaviors (postulated), MIR184-related
OMIM report
Human gene(s) implicated
Symptoms and phenotype

Late-life depression (LLD) is one of the most common mental disorders in the elderly, with prevalence rates ranging from 1% to 5% (for major depressive episodes). Its occurrence increases the risk of adverse health outcomes, including higher rates of medical morbidity, increased risk of Alzheimer's disease and vascular dementia. Beyond disease, LLD has been linked to decreased health span as measured by fewer years lived without frailty, significant functional impairments, elevated direct and indirect costs. (Mendes-Silva et al. 2019 and references cited therein, FBrf0241956.)

Genetics
Cellular phenotype and pathology

The presence of neurocognitive impairment is a very important feature of LLD (later-life depression) and is usually related to poorer outcomes, including higher risk of poor response to antidepressant treatment and development of dementia. Recent comprehensive, multi-modal biomarkers studies showed that subjects with LLD had significant abnormalities in biological pathways related to inflammatory response control, tissue remodeling, endothelial and vascular function, proteostasis, neurotrophic support, and enhanced molecular senescence abnormalities. (Mendes-Silva et al. 2019, FBrf0241956 and references cited therein.)

Molecular information
External links
Disease synonyms
Ortholog Information
Human gene(s) in FlyBase
    Human gene (HGNC)
    D. melanogaster ortholog (based on DIOPT)
    Comments on ortholog(s)

    Orthology based on Ibáñez-Ventoso et al. 2008, FBrf0215696.

    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (0)
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (0 groups)
        Alleles Reported to Model Human Disease (Disease Ontology) (0 alleles)
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        References (3)